PRIYA MEHTA

Employment

• Zydus Lifesciences ltd MSL
  2021 - Present
• Ganpat University ASSISTANT PROFESSOR
  2020 - 2021

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (4)

• Real-World Evaluation of Trastuzumab Emtansine Biosimilar in Early-Stage HER2-Positive Breast Cancer: Results from a Single-Center Retrospective Study in India
  Archives of Breast Cancer 2026 DOI: 10.32768/abc.2906718345-529
  +Save
• Clinical outcomes of neoadjuvant dual HER2 blockade with pertuzumab/Sigrima and trastuzumab/Vivitra biosimilars: real-world evidence in HER2-positive breast cancer in India
  International Journal of Research in Medical Sciences 2026 DOI: 10.18203/2320-6012.ijrms20260973
  +Save
• Favorable Outcome and Safety of Neoadjuvant Trastuzumab Emtansine (T-DM1) in a HER2-Positive Early Breast Cancer Patient with Severe Renal Disease on Hemodialysis Ineligible for Conventional Chemotherapy: A Case Report
  Reports 2023 DOI: 10.3390/reports6010013
  +Save
• Addition of trastuzumab emtansine (T-DM1) in a human epidermal growth factor receptor 2–overexpressed metastatic carcinoma of the gallbladder patient to enhance survival: A case study
  SAGE Open Medical Case Reports 2022 DOI: 10.1177/2050313X221137447
  +Save